ERBB2 and breast carcinoma: As a further application, we demonstrated that rapid‐ISH with AC mixing can be used to detect HER2 amplification within 6 hours in breast cancer patients 20, 21 and can detect Anaplastic lymphoma kinase break‐apart hybridization within 4.5 hours in lung cancer patients.22, 23